This is a news story, published by Yahoo Finance, that relates primarily to AMGN news.
For more AMGN news, you can click here:
more AMGN newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
excellent dividend track record. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest top dividend growth stock news, dividend growth stock news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
excellent dividend growth stockThe Motley Fool
•78% Informative
Amgen (NASDAQ: AMGN ) is one of the largest biotech companies in the world.
In the past 10 years , Amgen has increased its dividends by 269% .
The company's forward yield of 2.83% is well above the S&P 500's average of 1.35% Amgen 's cash dividend payout is about 65% .
VR Score
75
Informative language
73
Neutral language
15
Article tone
informal
Language
English
Language complexity
41
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
7
Source diversity
2
Affiliate links
no affiliate links